Pfizer’s Antiviral Pill for Covid Has Excellent Results


Published: December 19, 2021

New data recently released by Pfizer demonstrates that Paxlovid, the antiviral pill the company created to treat Covid patients, can reduce the risk of hospitalization or death by nearly 90% in high-risk adults. Pfizer also announced that preliminary results from a second study have shown that adult patients with a standard risk profile who take Paxlovid within a few days of showing symptoms of the virus have a 70% reduction of hospitalization and death.

Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.

Shop Now

Leave a Comment